Safety Evaluation of Intrathecal Substance P-Saporin, a Targeted Neurotoxin, in Dogs-Reference-Cited by-同舟云学术

Safety Evaluation of Intrathecal Substance P-Saporin, a Targeted Neurotoxin, in Dogs

Published:2006-02-24 Issue:1 Volume:91 Page:286-298
ISSN:1096-6080
Container-title:Toxicological Sciences
language:en
Short-container-title:

Author:

Allen Jeffrey W.,Mantyh Patrick W.,Horais Kjersti,Tozier Nicole,Rogers Scott D.,Ghilardi Joseph R.,Cizkova Dasa,Grafe Marjorie R.,Richter Phillip,Lappi Douglas A.,Yaksh Tony L.

Publisher

Oxford University Press (OUP)

Subject

Toxicology

Link

http://academic.oup.com/toxsci/article-pdf/91/1/286/10955444/kfj143.pdf

Reference34 articles.

1. Abbadie, C., Trafton, J., Liu, H., Mantyh, P. W., and Basbaum, A. I. (1997). Inflammation increases the distribution of dorsal horn neurons that internalize the neurokinin-1 receptor in response to noxious and non-noxious stimulation. J. Neurosci.17,8049–8060.

2. Dionne, R. A., Max, M. B., Gordon, S. M., Parada, S., Sang, C., Gracely, R. H., Sethna, N. F., and MacLean, D. B. (1998). The substance P receptor antagonist CP-99,994 reduces acute postoperative pain. Clin. Pharmacol. Ther.64,562–568.

3. Ferrer-Brechner, T. (1989). Anesthetic techniques for the management of cancer pain. Cancer63,2343–2347.

4. Flanigan, S., and Boop, W. C. (1974). Spinal intrathecal injection procedures in the management of pain. Clin. Neurosurg.21,229–238.

5. Goldstein, E. M. (2001). Spasticity management: An overview. J. Child Neurol.16,16–23.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuraxial Delivery of Targeted Toxins for Long-Term Pain Control;Neuraxial Therapeutics;2023

2. Preclinical Evaluation of Neuraxial Drugs for Safety;Neuraxial Therapeutics;2023

3. Saporin as a Commercial Reagent: Its Uses and Unexpected Impacts in the Biological Sciences—Tools from the Plant Kingdom;Toxins;2022-03-02

4. Pain Treatment in the Companion Canine Model to Validate Rodent Results and Incentivize the Transition to Human Clinical Trials;Frontiers in Pharmacology;2021-08-05

5. Chemodenervation: Neurolytic Blockade and Potent Neurotoxins for the Treatment of Cancer Pain;Deer's Treatment of Pain;2019